Skip to Main Content

You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.

Where Democrats’ resurrected drug pricing talks are headed


Democrats in the House and Senate have been furiously negotiating to achieve a grand bargain on drug pricing reform and prove a skeptical White House wrong, my colleague Rachel Cohrs reports. There hasn’t been any resolution as of Monday evening and discussions continue, but we have a general sense of where things are headed.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment

There was an error saving your display name. Please check and try again.